ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Paper TRMT61B rs4563180 G>C variant reduces hepatoblastoma risk: a case-control study of seven medical centers

Zeng, Dingyuan; Zhu, Jinhong; Li, Jingjing; Liao, Fan; Yang, Zhonghua; Li, Yong; Zhang, Jiao; Cheng, Jiwen; Li, Suhong; Li, Li*; He, Jing*广州医学院; 哈尔滨医科大学; 郑州大学; 西安交通大学; 中国医科大学; 1
Aging-US2023-8-15
8阅读
引用收藏
分享

摘要

N1-methyladenosine (m1A) is an essential chemical modification of RNA. Dysregulation of RNA m1A modification and m1A-related regulators is detected in several adult tumors. Whether aberrant RNA m1A modification is involved in hepatoblast carcinogenesis has not been reported. tRNA methyltransferase 61B (TRMT61B) is responsible for mitochondrial RNA m1A modification. Some evidence has shown that genetic variants of TRMT61B might contribute to cancer susceptibility; however, its roles in hepatoblastoma are unknown. This study attempted to discover novel hepatoblastoma susceptibility loci. With the TaqMan method, we examined genotypes of the TRMT61B rs4563180 G>C polymorphism among germline DNA samples from 313 cases and 1446 controls. The association of the rs4563180 G>C polymorphism with hepatoblastoma risk was estimated based on odds ratios (ORs) and 95% confidence intervals (CIs). We found that the TRMT61B rs4563180 G>C polymorphism correlated significantly with a reduction in hepatoblastoma risk (GC vs. GG: adjusted OR=0.65, 95% CI=0.49-0.85, P=0.002; GC/CC vs. GG: adjusted OR=0.66, 95% CI=0.51-0.85, P=0.002). In stratified analysis, significant associations were detected in children younger than 17 months old, girls, and subgroups with stage I+II or III+IV tumors. False-positive report probability analysis validated that children with the GC or CC genotype, particularly in those <17 months of age, had a decreased risk of hepatoblastoma. The rs4563180 G>C polymorphism also correlated with expression of TRMT61B and the nearby gene PPP1CB. We identified a high-quality biomarker measuring hepatoblastoma susceptibility, which may contribute to future screening programs.

学科与关键词

关键词
hepatoblastomasusceptibilityTRMT61BpolymorphismHan Chinese
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Aging-US
发表日期
2023-08-15
卷期
第 15 卷, 第 15 期
页码
7583-7592
语言
ENGLISH
成果收录
SCIE
资助标注
Guangxi Science and Technology Plan Project (Guangxi Clinical Research Center for Obstetrics and Gynecology) [AD22035223]; Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease [2019B030301004]

作者

  • Z

    Zeng, Dingyuan (第一作者)

    guangzhou women & childrens med ctr

  • Z

    Zhu, Jinhong

    harbin med univ

查看全部 11 位作者收起作者
  • L

    Li, Jingjing

    guangzhou women & childrens med ctr

  • L

    Liao, Fan

    guangzhou med univ · guangzhou women & childrens med ctr

  • Y

    Yang, Zhonghua

    china med univ

  • L

    Li, Yong

    hunan childrens hosp

  • Z

    Zhang, Jiao

    1 · zhengzhou univ

  • C

    Cheng, Jiwen

    2 · xi an jiao tong univ

  • L

    Li, Suhong

  • L

    Li, Li (通讯)

  • H

    He, Jing (通讯)

    guangzhou women & childrens med ctr · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417